The natural history of asymptomatic central venous catheter-related thrombosis in critically ill children.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
21 02 2019
Historique:
received: 06 05 2019
accepted: 24 10 2019
pubmed: 1 11 2018
medline: 24 10 2019
entrez: 1 11 2018
Statut: ppublish

Résumé

Asymptomatic central venous catheter (CVC)-related thrombosis in children varies in incidence from 5% to 69%. The rate of acute and long-term complications, such as postthrombotic syndrome (PTS), from asymptomatic CVC-related thrombosis is unknown. This article reports the outcomes of a prospective study of 189 children in pediatric intensive care that aimed to determine the frequency of asymptomatic CVC-related thrombosis during hospital admission, and the incidence of residual CVC-related thrombosis and clinically significant PTS 2 years later. Risk factors associated with CVC-related thrombosis were also identified. This study is distinct from previous work as children identified to have asymptomatic CVC-related thrombosis were not treated (clinical team kept blinded) and the entire cohort was followed for 2 years to determine the natural history of asymptomatic thrombosis. Ultrasounds of 146 children determined a 21.9% incidence of acute CVC-related thrombosis. Two children were symptomatic. No radiological thrombosis extension or clinical embolization occurred in the 126 children assessed at follow-up. Using 2 recognized PTS scales, clinically significant PTS was reported in 2 children (1 symptomatic, 1 asymptomatic CVC-related thrombosis), however, neither had functional impairment. Cardiac arrest was a risk factor for CVC-related thrombosis during admission and femoral CVC placement was predictive of residual thrombosis 2 years later. This study challenges the notion that critically ill children with asymptomatic CVC-related thrombosis require anticoagulant treatment, as the results demonstrate that the incidence of acute or long-term complications is low. A larger confirmatory study of nontreatment of CVC-related thrombosis in critically ill children is justified.

Identifiants

pubmed: 30377196
pii: S0006-4971(20)42774-0
doi: 10.1182/blood-2018-05-849737
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

857-866

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2019 by The American Society of Hematology.

Auteurs

Sophie Jones (S)

Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.
Haematology Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Department of Clinical Haematology, The Royal Children's Hospital, Melbourne, VIC, Australia.
Department of Nursing, The University of Melbourne, Melbourne, VIC, Australia; and.

Warwick Butt (W)

Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.
Paediatric Intensive Care Unit.

Paul Monagle (P)

Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.
Haematology Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Department of Clinical Haematology, The Royal Children's Hospital, Melbourne, VIC, Australia.

Timothy Cain (T)

Medical Imaging Department, and.

Fiona Newall (F)

Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.
Haematology Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Department of Clinical Haematology, The Royal Children's Hospital, Melbourne, VIC, Australia.
Department of Nursing, The University of Melbourne, Melbourne, VIC, Australia; and.
Department of Nursing Research, The Royal Children's Hospital, Melbourne, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH